Laos vs Northern Africa and Western Asia: Percentage of bloodstream infection due … methicillin-resistant
Laos
55.9%
in 2022
Northern Africa and Western Asia
42.1%
in 2022
Laos rank
6th
Northern Africa and Western Asia rank
8th
Percentage of bloodstream infection due … methicillin-resistant over time
- Laos
- Northern Africa and Western Asia
How they compare
Laos currently reports 55.9% against 42.1% in Northern Africa and Western Asia, a difference of 13.8%.
That makes Laos's figure about 1.3 times Northern Africa and Western Asia's.
The two have swapped places 1 time across 6 shared years of data; in 2017 it was Northern Africa and Western Asia ahead.
Laos ranks 6th and Northern Africa and Western Asia ranks 8th of 50 countries.
Across the 2 decades both report, Laos averaged higher in 1 and Northern Africa and Western Asia in 1.
Head to head by decade
| Decade | Laos | Northern Africa and Western Asia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 9.0% | 33.9% | 24.9% | Northern Africa and Western Asia |
| 2020s | 45.3% | 44.4% | 0.8% | Laos |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to methicillin-resistant, Laos or Northern Africa and Western Asia?
- Laos, at 55.9% against 42.1% in Northern Africa and Western Asia as of 2022.
- What is the difference in percentage of bloodstream infection due to methicillin-resistant between Laos and Northern Africa and Western Asia?
- 13.8%, with Laos ahead.
- How many years of comparable data are there for Laos and Northern Africa and Western Asia?
- 6 years are reported by both, from 2017 to 2022.
- How do Laos and Northern Africa and Western Asia rank globally for percentage of bloodstream infection due to methicillin-resistant?
- Laos ranks 6th and Northern Africa and Western Asia ranks 8th of 50 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.